GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
LowReport
GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
GE HealthCare Technologies Inc. (NASDAQ: GEHC) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $100.00 price target on the stock, up previously from $85.00.
LowReport
GE HealthCare Technologies Inc. (NASDAQ: GEHC) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $100.00 price target on the stock, up previously from $85.00.
GE HealthCare Technologies Inc. (NASDAQ: GEHC) had its price target raised by analysts at Wells Fargo & Company from $96.00 to $103.00. They now have an "overweight" rating on the stock.
LowReport
GE HealthCare Technologies Inc. (NASDAQ: GEHC) had its price target raised by analysts at Wells Fargo & Company from $96.00 to $103.00. They now have an "overweight" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: